What Walgreens’ $10 billion private equity deal means for consumers, pharmacy industry

What Walgreens’ $10 billion private equity deal means for consumers, pharmacy industry

After years of financial turmoil, Walgreens recently announced that it has reached a $10 billion buyout deal with private-equity firm Sycamore — a move that likely will have wide-ranging consequences for how consumers access health care and health-care products, according to Olin Business School experts Patrick Aguilar and Peter Boumgarden.
Job/Security

Job/Security

A Composite Portrait of the Expanding American Security Industry

Co-authored by Edward Schwarzschild, AM ’89, PhD ’94, the book is an illuminating collection of candid interviews and photographs with workers in America’s burgeoning security state.
A Tyranny for the Good of its Victims

A Tyranny for the Good of its Victims

The Ugly Truth about Stakeholder Capitalism

Over the last 35 years, asset manager mega-giants BlackRock, State Street, and Vanguard have accumulated unprecedented levels of stock ownership in virtually every major U.S. company. Voting the shares they hold for clients allows these companies to force their own “environmental, social, and governance” or “ESG” agenda on the American corporate sector and, by extension, […]
Older Stories